There's what I think is a new posting on clinical trials.gov with the information on the Phase 2 trial. It states that the trial should end in April 2013, which is later than what I had expected. I believe that it was stated that it would end at the end of 2012. I know that was said at some point in the past. So, I don't really know what we have for "news" for a while. That is the only negative thing that I could find. The pullback appears to be completely overblown. I have no intention of selling this anytime in the next year, but I'd still like to see it behave more rationally up or down.